CLA, or conjugated linoleic acid, is a type of fatty acid doctors have been studying for immunity for several years. In this trial, 13 people with moderately active Crohn’s disease-a chronic autoimmune inflammatory gastrointestinal disorder-took 6,000 mg of CLA per day. This was an “open label” study, with everyone aware of the treatment and no placebo group. After 12 weeks, levels of several immune inflammatory molecules were much lower, and the Crohn’s disease activity index improved from “moderate” to “mild”. Participants also needed less medication and reported better overall quality of life, with most symptoms nearly receding into remission.
Reference: Journal of Clinical Nutrition; 2012, Vol. 31, No. 5, 721-7
From the March 2013 newsletter
RSS